Is Universal Next-Generation Sequencing Testing of Patients With Advanced Cancer Ready for Prime Time?—Reply-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Is Universal Next-Generation Sequencing Testing of Patients With Advanced Cancer Ready for Prime Time?—Reply

Published:2021-08-01 Issue:8 Volume:7 Page:1246
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Cobain Erin F.¹,Chinnaiyan Arul M.²³⁴⁵⁶

Affiliation:

1. Department of Internal Medicine, University of Michigan, Ann Arbor

2. Michigan Center for Translational Pathology, University of Michigan, Ann Arbor

3. Department of Pathology, University of Michigan, Ann Arbor

4. Rogel Cancer Center, University of Michigan, Ann Arbor

5. Department of Urology, University of Michigan, Ann Arbor

6. Howard Hughes Medical Institute, University of Michigan, Ann Arbor

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2780918/jamaoncology_cobain_2021_lr_210014_1628879192.08696.pdf

Reference6 articles.

1. Assessment of clinical benefit of integrative genomic profiling in advanced solid tumors.;Cobain;JAMA Oncol,2021

2. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial.;Le Tourneau;Lancet Oncol,2015

3. Comparison of universal genetic testing vs guideline-directed targeted testing for patients with hereditary cancer syndrome.;Samadder;JAMA Oncol,2021

4. Evaluation of germline genetic testing criteria in a hospital-based series of women with breast cancer.;Yadav;J Clin Oncol,2020

5. Underdiagnosis of hereditary breast and ovarian cancer in Medicare patients: genetic testing criteria miss the mark.;Yang;Ann Surg Oncol,2018

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Utility of Molecular Tumor Board Review for Identification of Possible Germline Pathogenic Variants on Tumor Next-Generation Sequencing Reports;JCO Precision Oncology;2024-09

2. Clinical impact of panel gene sequencing on therapy of advanced cancers of the digestive system: a retrospective, single center study;BMC Cancer;2024-04-25

3. Genome-matched treatments and patient outcomes in the Maine Cancer Genomics Initiative (MCGI);npj Precision Oncology;2024-03-09

4. A functional personalised oncology approach against metastatic colorectal cancer in matched patient derived organoids;npj Precision Oncology;2024-02-27

5. Determinants Affecting the Clinical Implementation of a Molecularly Informed Molecular Tumor Board Recommendation: Experience from a Tertiary Cancer Center;Cancers;2023-12-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3